ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MDSO Medidata Solutions Inc

92.22
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Medidata Solutions Inc NASDAQ:MDSO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 92.22 92.24 92.25 0 01:00:00

Medidata to Present at J.P. Morgan 35th Annual Healthcare Conference

03/01/2017 1:30pm

Business Wire


Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Medidata Solutions Charts.

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann, chief financial officer, will present at the J.P. Morgan 35th Annual Healthcare Conference on Thursday, January 12, 2017, at 8:00 a.m. PT (11:00 a.m. ET) in San Francisco.

A live audio webcast will be available on the “Investor” section of Medidata’s website at http://investor.mdsol.com. Please visit the website at least 15 minutes prior to the event to register, download and install any necessary audio or video software to access the presentation. For those unable to participate in the live webcast, a replay will be archived on the “Investor” section of Medidata’s website at http://investor.mdsol.com for a limited period of time following the conference.

About Medidata

Medidata is reinventing global drug development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including nearly 800 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.

The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 17 of the world's top 25 global pharmaceutical companies, from study design and planning through execution, management and reporting.

Investors:Medidata SolutionsAnthony D’Amico, +1 732-767-4331adamico@mdsol.comorMedia:Medidata SolutionsNicole Pariser, +1 212-659-1069npariser@mdsol.com

1 Year Medidata Solutions Chart

1 Year Medidata Solutions Chart

1 Month Medidata Solutions Chart

1 Month Medidata Solutions Chart

Your Recent History

Delayed Upgrade Clock